By improving the deregulated metabolism of adipose tissues through specific peripheral CB1R antagonism, we found the dysregulated synthesis and secretion of adipokines were thus rectified, and furthermore a comprehensive metabolic improvement including counteracting obesity, improving dyslipidemia and insulin resistance was realized by AM6545 in the MSG mice. The gene discussed is CNR1; the disease is metabolic syndrome.